Can Dexamethasone Cause Tremors?
Tremor is not a commonly reported or well-documented adverse effect of dexamethasone in the major clinical guidelines and studies, though it may occur as part of broader neurological or neurotoxic effects in specific contexts.
Evidence from Clinical Guidelines
The available guideline evidence does not identify tremor as a primary or common adverse effect of dexamethasone therapy:
In studies of high-dose dexamethasone for malignant spinal cord compression, the documented serious adverse effects included severe psychoses, gastric ulcers, hemorrhage, rectal bleeding, and gastrointestinal perforations—but tremor was not specifically mentioned 1.
A case-control study comparing high-dose versus moderate-dose dexamethasone reported serious adverse effects in 14% of patients on high doses (ulcers with hemorrhage, rectal bleeding, gastrointestinal perforations) and 29% experiencing any adverse effects, but again tremor was not listed 1.
In the context of CAR T-cell therapy neurotoxicity management, guidelines note that "other signs and symptoms such as headache, tremor, myoclonus, asterixis, and hallucinations may occur and could be attributable to immune effector cell-engaging therapies," but this refers to the underlying condition being treated rather than dexamethasone itself 2, 3.
Context-Specific Considerations
When tremor is mentioned in association with dexamethasone, it appears in specific clinical contexts:
The ASCO guideline for CAR T-cell therapy mentions tremor as a potential sign of immune effector cell-associated neurotoxicity syndrome (ICANS), where dexamethasone is used as treatment rather than cause 2.
The NCCN guidelines similarly note that tremor may occur in patients receiving CAR T-cell therapy, but this is attributed to the therapy itself or underlying neurological complications, not the dexamethasone used to manage these complications 3.
Neurological Effects of Dexamethasone
While tremor is not prominently featured, dexamethasone does have documented neurological effects:
High-dose dexamethasone can cause severe psychoses requiring intervention 1.
Preclinical research suggests dexamethasone can induce neuronal damage in specific brain regions including the striatum and hippocampus, which theoretically could affect motor control, though clinical tremor was not specifically documented 4.
Animal studies show that neonatal dexamethasone exposure can permanently alter central nervous system function and stress responses, though tremor was not a measured outcome 5.
General Drug-Induced Tremor Context
- A comprehensive review of drug-induced tremor lists numerous medications associated with tremor (amiodarone, SSRIs/SNRIs, lithium, valproate, β-agonists, dopamine antagonists) but does not include corticosteroids or dexamethasone among the common culprits 6.
Clinical Approach
If a patient on dexamethasone develops tremor, consider:
Alternative etiologies first: The tremor is more likely related to the underlying condition being treated, concurrent medications, metabolic derangements, or other factors rather than dexamethasone itself 6.
Dose-related effects: Higher doses of dexamethasone (≥16 mg/day) are associated with increased adverse effects overall, though tremor is not specifically highlighted 1, 7.
Duration of therapy: Prolonged high-dose therapy increases risk of various neurological complications including psychoses, though tremor remains poorly documented 1, 7.
Clinical Pitfalls
Do not automatically attribute tremor to dexamethasone without considering more common causes of drug-induced tremor 6.
Be aware that in oncology patients receiving dexamethasone, tremor may be related to the underlying malignancy, brain metastases, metabolic abnormalities, or concurrent medications rather than the steroid itself 1, 2, 3.
In patients receiving immunotherapy or CAR T-cell therapy, tremor is more likely a manifestation of immune-mediated neurotoxicity rather than a dexamethasone side effect 2, 3.